biote Corp. (BTMD)
NASDAQ: BTMD
· Real-Time Price · USD
3.79
-0.16 (-4.05%)
At close: Jun 13, 2025, 3:59 PM
3.79
0.00%
After-hours: Jun 13, 2025, 04:58 PM EDT
biote Revenue Breakdown
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
---|---|---|---|
Dietary Supplements Revenue | 36.02M | 38.09M | 32.41M |
Dietary Supplements Revenue Growth | -5.44% | +17.52% | n/a |
Other Service Revenue Revenue | 2.27M | 697K | 163.13M |
Other Service Revenue Revenue Growth | +225.54% | -99.57% | n/a |
Product Revenue Revenue | 192.24M | 182.57M | 1.82M |
Product Revenue Revenue Growth | +5.29% | +9909.48% | n/a |
Service Revenue Revenue | 4.95M | 2.79M | 973K |
Service Revenue Revenue Growth | +77.65% | +186.43% | n/a |
Training Service Revenue Revenue | 1.46M | 1.17M | n/a |
Training Service Revenue Revenue Growth | +24.44% | n/a | n/a |
Revenue by Geography
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
---|---|---|---|
United States Revenue | 196.2M | 735K | 434K |
United States Revenue Growth | +26593.88% | +69.35% | n/a |
All Other Country Revenue | 1.02M | 181.84M | 164.52M |
All Other Country Revenue Growth | -99.44% | +10.52% | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 26.69M | 32.76M | 24.03M | 27.65M | 22.26M | 20.12M | 23.79M | 25.76M | 23.09M | 21.57M | 20.61M | 113.06M | 14.89M | 17.64M | 13.73M | 12.39M | 10.79M | 9.5M |
Selling, General, and Administrative Revenue Growth | -18.53% | +36.35% | -13.10% | +24.21% | +10.64% | -15.43% | -7.64% | +11.59% | +7.01% | +4.67% | -81.77% | +659.47% | -15.59% | +28.47% | +10.83% | +14.80% | +13.58% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |